Related references
Note: Only part of the references are listed.2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b] thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice
Jin Zhang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
Sarah K. Orr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Autophagy in the light of sphingolipid metabolism
Eva Bang Harvald et al.
APOPTOSIS (2015)
Roles of Acyl-CoA: Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes
Chen Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization
Kun Liu et al.
AUTOPHAGY (2015)
Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death
Yusuke Toki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action
Ying Liu et al.
BIOCHEMICAL JOURNAL (2015)
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Olof Radmark et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
The pharmacology of resveratrol in animals and humans
Eun-Jung Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice
P. G. Trentin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin
C. Torricelli et al.
CANCER LETTERS (2015)
Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
Amna Abderrazak et al.
CIRCULATION (2015)
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease
Irina A. Kirpich et al.
CLINICAL BIOCHEMISTRY (2015)
CXCR3 ligands in disease and therapy
Katrien Van Raemdonck et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
Shihui Chen et al.
DIGESTIVE AND LIVER DISEASE (2015)
Targeting xenobiotic receptors PXR and CAR in human diseases
Monimoy Banerjee et al.
DRUG DISCOVERY TODAY (2015)
Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice
Nicholas Douris et al.
ENDOCRINOLOGY (2015)
Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro
Xuguang Zhai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Saroglitazar for the treatment of dyslipidemia in diabetic patients
Shashank R. Joshi
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Poster Session 4: Steatohepatitis: Clinical and Therapeutic
HEPATOLOGY (2015)
Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice
Su-Yeon Lee et al.
HEPATOLOGY (2015)
Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: All that is gold does not glitter, not all those who wander are lost
Giovanni Musso
HEPATOLOGY (2015)
A new mechanism of lipotoxicity: Calcium channel blockers as a treatment for nonalcoholic steatohepatitis?
Mark J. Czaja
HEPATOLOGY (2015)
ALCAT1 Controls Mitochondrial Etiology of Fatty Liver Diseases, Linking Defective Mitophagy to Steatosis
Li Wang et al.
HEPATOLOGY (2015)
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
Natalie J. Torok et al.
HEPATOLOGY (2015)
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
Irina Kufareva et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Activation of mTORC1 disrupted LDL receptor pathway: A potential new mechanism for the progression of non-alcoholic fatty liver disease
Jing Liu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Effects of formulation design on niacin therapeutics: mechanism of action, metabolism, and drug delivery
Dustin L. Cooper et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
Chengfu Xu et al.
JOURNAL OF HEPATOLOGY (2015)
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
Vasundhara Kain et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Endogenous and exogenous mediators of quercetin bioavailability
Yi Guo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
Xinlu Yuan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease
Shobha H. Ganji et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
Ilija Jeftic et al.
MOLECULAR MEDICINE (2015)
The emerging role of redox-sensitive Nrf2-Keap1 pathway in diabetes
Elango Bhakkiyalakshmi et al.
PHARMACOLOGICAL RESEARCH (2015)
Cardioprotective potential of annexin-A1 mimetics in myocardial infarction
Chengxue Qin et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
Silvia S. Chambel et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms
Andreas Bitter et al.
ARCHIVES OF TOXICOLOGY (2015)
Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury
Vladislav Volarevic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Galectin-3: an emerging all-out player in metabolic disorders and their complications
Giuseppe Pugliese et al.
GLYCOBIOLOGY (2015)
Galectin-3 regulates hepatic progenitor cell expansion during liver injury
Wei-Chen Hsieh et al.
GUT (2015)
Treatment Response in the PIVENS Trial Is Associated With Decreased Hedgehog Pathway Activity
Cynthia D. Guy et al.
HEPATOLOGY (2015)
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
George N. Ioannou et al.
JOURNAL OF LIPID RESEARCH (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
Takhar Kasumov et al.
PLOS ONE (2015)
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
Petra Hirsova et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice
Xianlong Ye et al.
ENDOCRINE (2015)
Pregnane X Receptor Modulates the Inflammatory Response in Primary Cultures of Hepatocytes
Mengxi Sun et al.
DRUG METABOLISM AND DISPOSITION (2015)
SLC13A5 Is a Novel Transcriptional Target of the Pregnane X Receptor and Sensitizes Drug-Induced Steatosis in Human Liver
Linhao Li et al.
MOLECULAR PHARMACOLOGY (2015)
An Overview of Hedgehog Signaling in Fibrosis
Liping Hu et al.
MOLECULAR PHARMACOLOGY (2015)
Roles of Oxidized Diacylglycerol for Carbon Tetrachloride-induced Liver Injury and Fibrosis in Mouse
Susumu Takekoshi et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2014)
Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease
Shobha H. Ganji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Activation of N-methyl-D-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway
Ahmad Farooq et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin
Elina Isakov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease
Georgios Grammatikos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response
Hongliang Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling
Erawan Borkham-Kamphorst et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Discovery of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors with a 1H-Pyrrolo[2,3-b]pyridine Core
Mun Ock Kim et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Human lysyl oxidase-like 2
Hee-Jung Moon et al.
BIOORGANIC CHEMISTRY (2014)
Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
Hugo You-Hsien Lin et al.
BMC IMMUNOLOGY (2014)
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
Atsushi Umemura et al.
CELL METABOLISM (2014)
Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells
Zhuo-Jian Li et al.
CELLULAR SIGNALLING (2014)
Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
Eric Jnoff et al.
CHEMMEDCHEM (2014)
Disruption of Mammalian Target of Rapamycin Complex 1 in Macrophages Decreases Chemokine Gene Expression and Atherosclerosis
Ding Ai et al.
CIRCULATION RESEARCH (2014)
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
Veronique S. Chachay et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
Andrea Carotti et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
FGF21 Maintains Glucose Homeostasis by Mediating the Cross Talk Between Liver and Brain During Prolonged Fasting
Qingning Liang et al.
DIABETES (2014)
Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice
Hongfeng Jiang et al.
DIABETOLOGIA (2014)
Liver-Enriched Transcription Factor CREBH Interacts With Peroxisome Proliferator-Activated Receptor α to Regulate Metabolic Hormone FGF21
Hyunbae Kim et al.
ENDOCRINOLOGY (2014)
Discontinued in 2013: diabetic drugs
Maka S. Hedrington et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis
Bibiana Rius et al.
FASEB JOURNAL (2014)
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice
Wei-Hsuan Hsu et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
Resveratrol modulates autophagy and NF-kappa B activity in a murine model for treating non-alcoholic fatty liver disease
Lake Li et al.
FOOD AND CHEMICAL TOXICOLOGY (2014)
694 Hepatic CXCR3 Promotes Non-Alcoholic Steatohepatitis Through Inflammation, Lipid Accumulation and Autophagy Deficiency
Xiang Zhang et al.
GASTROENTEROLOGY (2014)
Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
Ffolliott M. Fisher et al.
GASTROENTEROLOGY (2014)
Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21
Yu Li et al.
GASTROENTEROLOGY (2014)
Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and Fibrosis
Linda Hammerich et al.
HEPATOLOGY (2014)
Hepatic Cannabinoid-1 Receptors Mediate Diet-Induced Insulin Resistance by Increasing De Novo Synthesis of Long-Chain Ceramides
Resat Cinar et al.
HEPATOLOGY (2014)
Free Cholesterol Accumulation in Hepatic Stellate Cells: Mechanism of Liver Fibrosis Aggravation in Nonalcoholic Steatohepatitis in Mice
Kengo Tomita et al.
HEPATOLOGY (2014)
Epidermal Growth Factor Receptor Inhibition Attenuates Liver Fibrosis and Development of Hepatocellular Carcinoma
Bryan C. Fuchs et al.
HEPATOLOGY (2014)
Fructose Leads to Hepatic Steatosis in Zebrafish That Is Reversed by Mechanistic Target of Rapamycin (mTOR) Inhibition
Valerie Sapp et al.
HEPATOLOGY (2014)
Endogenous Annexin A1 Is a Novel Protective Determinant in Nonalcoholic Steatohepatitis in Mice
Irene Locatelli et al.
HEPATOLOGY (2014)
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Andreas L. Birkenfeld et al.
HEPATOLOGY (2014)
Pharmacological Inhibition of the Chemokine C-C Motif Chemokine Ligand 2 (Monocyte Chemoattractant Protein 1) Accelerates Liver Fibrosis Regression by Suppressing Ly-6C+ Macrophage Infiltration in Mice
Christer Baeck et al.
HEPATOLOGY (2014)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
The Transrepressive Activity of Peroxisome Proliferator-Activated Receptor Alpha Is Necessary and Sufficient to Prevent Liver Fibrosis in Mice
Michal Pawlak et al.
HEPATOLOGY (2014)
The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men
E. Konings et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
Laura Perez-Martinez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis
Shan Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Sayaka Inokuchi-Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
David Castano et al.
JOURNAL OF HEPATOLOGY (2014)
ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis
Raquel Fucho et al.
JOURNAL OF HEPATOLOGY (2014)
Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation
Hiroe Honda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
Lazar A. Bojic et al.
JOURNAL OF LIPID RESEARCH (2014)
Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1
Jing Dong et al.
JOURNAL OF LIPID RESEARCH (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Chronic supplementation of proanthocyanidins reduces postprandial lipemia and liver miR-33a and miR-122 levels in a dose-dependent manner in healthy rats
Laura Baselga-Escudero et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance
P. J. Meakin et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells
Tae Woo Jung et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase
Jing Li et al.
LIFE SCIENCES (2014)
Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?
James M. Smoliga et al.
MOLECULES (2014)
Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
Krzysztof Kurek et al.
LIVER INTERNATIONAL (2014)
Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis
Timea Csak et al.
LIVER INTERNATIONAL (2014)
Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
Laura Baselga-Escudero et al.
NUCLEIC ACIDS RESEARCH (2014)
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
Joao Marcus Oliveira Andrade et al.
NUTRITION (2014)
Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice
Wei Zhu et al.
NUTRITION & METABOLISM (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
Paola Stiuso et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Anne Cleasby et al.
PLOS ONE (2014)
Inflammatory Stress Increases Hepatic CD36 Translational Efficiency via Activation of the mTOR Signalling Pathway
Chuan Wang et al.
PLOS ONE (2014)
Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
Virender Kumar et al.
PHARMACEUTICAL RESEARCH (2014)
Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes
Darwin V. Lee et al.
PLOS ONE (2014)
Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury
Alexander Wehr et al.
PLOS ONE (2014)
Ceramide: A simple sphingolipid with unique biophysical properties
Bruno M. Castro et al.
PROGRESS IN LIPID RESEARCH (2014)
Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A: diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver
Xiaomang Xing et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells
Xiao-Min Xin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
Albert J. Czaja
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
A. Gonzalez-Rodriguez et al.
CELL DEATH & DISEASE (2014)
Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway
Xiaoge Gao et al.
ONCOTARGET (2014)
Induction of ER stress-mediated apoptosis by ceramide via disruption of ER Ca2+ homeostasis in human adenoid cystic carcinoma cells
Zhe Liu et al.
CELL AND BIOSCIENCE (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Inhibition of acid sphingonnyelinase by tricyclic antidepressants and analogons
Nadine Beckmann et al.
FRONTIERS IN PHYSIOLOGY (2014)
Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat
Aldo Roda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury
Maryna Perepelyuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors
Ziwei Xiao et al.
CARCINOGENESIS (2013)
Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation
Kun Ling Ma et al.
CARDIOVASCULAR RESEARCH (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
High-Dose Resveratrol Supplementation in Obese Men An Investigator-Initiated, Randomized, Placebo-Controlled Clinical Trial of Substrate Metabolism, Insulin Sensitivity, and Body Composition
Morten M. Poulsen et al.
DIABETES (2013)
Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
Giovanni Musso et al.
DIABETES (2013)
Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
Nada N. Pejnovic et al.
DIABETES (2013)
The Sphingosine-1-Phosphate Analog FTY720 Reduces Muscle Ceramide Content and Improves Glucose Tolerance in High Fat-Fed Male Mice
Clinton R. Bruce et al.
ENDOCRINOLOGY (2013)
Roles of Chemokine Ligand-2 (CXCL2) and Neutrophils in Influencing Endothelial Cell Function and Inflammation of Human Adipose Tissue
Christine Rouault et al.
ENDOCRINOLOGY (2013)
Attenuation of plasma annexin A1 in human obesity
Anna Kosicka et al.
FASEB JOURNAL (2013)
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
Hua-Zhong Ying et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
Maximilian Hatting et al.
HEPATOLOGY (2013)
C-C Motif Chemokine Receptor 9 Positive Macrophages Activate Hepatic Stellate Cells and Promote Liver Fibrosis in Mice
Po-sung Chu et al.
HEPATOLOGY (2013)
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
Kouichi Miura et al.
HEPATOLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells
Denis A. Mogilenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies IMPLICATIONS FOR DEGRADATION OF NRF2 IN THE NUCLEUS
Melanie Theodore Malloy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasive in Vitro
Hee-Jung Moon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair
Giovanna Leoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
SIMTUZUMAB, AN ANTIFIBROTIC MONOCLONAL ANTIBODY AGAINST LYSYL OXIDASE-LIKE 2 (LOXL2) ENZYME, APPEARS SAFE AND WELL TOLERATED IN PATIENTS WITH LIVER DISEASE OF DIVERSE ETIOLOGY
A. H. Talal et al.
JOURNAL OF HEPATOLOGY (2013)
Proresolving and Tissue-Protective Actions of Annexin A1-Based Cleavage-Resistant Peptides Are Mediated by Formyl Peptide Receptor 2/Lipoxin A4 Receptor
Jesmond Dalli et al.
JOURNAL OF IMMUNOLOGY (2013)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
Alexander Wehr et al.
JOURNAL OF IMMUNOLOGY (2013)
Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
Ki-Hyun Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway
Kentaro Toriumi et al.
LABORATORY INVESTIGATION (2013)
Nrf2 deletion causes benign simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet
Chunhua Wang et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Discovery of indolyl acrylamide derivatives as human diacylglycerol acyltransferase-2 selective inhibitors
Kyeong Lee et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2013)
PKCδ as a Regulator for TGFβ1-Induced α-SMA Production in a Murine Nonalcoholic Steatohepatitis Model
Su Jin Lee et al.
PLOS ONE (2013)
Quercetin Induces Hepatic Lipid Omega-Oxidation and Lowers Serum Lipid Levels in Mice
Elise F. Hoek-van den Hil et al.
PLOS ONE (2013)
Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
Jingbo Pang et al.
PLOS ONE (2013)
Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
Laura J. Dixon et al.
PLOS ONE (2013)
LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys
Andrew C. Adams et al.
PLOS ONE (2013)
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
Petra Hirsova et al.
PLOS ONE (2013)
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Peter G. Traber et al.
PLOS ONE (2013)
Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver Disease
Peter G. Traber et al.
PLOS ONE (2013)
Increased Adiposity in Annexin A1-Deficient Mice
Rand T. Akasheh et al.
PLOS ONE (2013)
Identification of Three Novel Natural Product Compounds that Activate PXR and CAR and Inhibit Inflammation
Suticha Kittayaruksakul et al.
PHARMACEUTICAL RESEARCH (2013)
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Nazila Kamaly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2013)
Interactions between Human Liver Fatty Acid Binding Protein and Peroxisome Proliferator Activated Receptor Selective Drugs
Tony Velkov
PPAR RESEARCH (2013)
Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis-Related Fibrosis in a Dietary Rat Model
Rieko Shimozono et al.
MOLECULAR PHARMACOLOGY (2013)
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Kouichi Miura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Myeloid Deletion of Nuclear Factor Erythroid 2-Related Factor 2 Increases Atherosclerosis and Liver Injury
Alan R. Collins et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
S. Gomez-Zorita et al.
BRITISH JOURNAL OF NUTRITION (2012)
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
Su-Jung Cho et al.
BRITISH JOURNAL OF NUTRITION (2012)
Mir-33 regulates cell proliferation and cell cycle progression
Daniel Cirera-Salinas et al.
CELL CYCLE (2012)
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
Hae-Ki Min et al.
CELL METABOLISM (2012)
Increased Macrophage Migration Into Adipose Tissue in Obese Mice
Da Young Oh et al.
DIABETES (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling
Chang Joo Oh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver
KyeongJin Kim et al.
HEPATOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2
Minsheng Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
Annie-Carole Tosello-Trampont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
Joan Claria et al.
JOURNAL OF IMMUNOLOGY (2012)
Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease
Sorina Georgiana Boaru et al.
JOURNAL OF INFLAMMATION-LONDON (2012)
Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis
Juliana P. Vago et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Quercetin Ameliorates Cardiovascular, Hepatic, and Metabolic Changes in Diet-Induced Metabolic Syndrome in Rats
Sunil K. Panchal et al.
JOURNAL OF NUTRITION (2012)
Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
Andrew C. Adams et al.
PLOS ONE (2012)
Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes
Randy Hecht et al.
PLOS ONE (2012)
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats
Pankaj K. Bagul et al.
PHARMACOLOGICAL RESEARCH (2012)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Tatiana Kisseleva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex
Ian N. Foltz et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor
Guodong Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Acetylation of pregnane X receptor protein determines selective function independent of ligand activation
Arunima Biswas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Role of S6K1 in regulation of SREBP1c expression in the liver
Shuying Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Timothy R. Peterson et al.
CELL (2011)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Regulation of Lipid Homeostasis by the Bifunctional SREBF2-miR33a Locus
Guido T. Bommer et al.
CELL METABOLISM (2011)
Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice
Z. Yu et al.
DIABETOLOGIA (2011)
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
Harold E. Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice
William L. Holland et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
Carla Iacobini et al.
JOURNAL OF HEPATOLOGY (2011)
DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes
Charles A. Harris et al.
JOURNAL OF LIPID RESEARCH (2011)
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
William L. Holland et al.
NATURE MEDICINE (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
The Human Serum Metabolome
Nikolaos Psychogios et al.
PLOS ONE (2011)
Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
D. Lee Gorden et al.
PLOS ONE (2011)
Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
George M. Philips et al.
PLOS ONE (2011)
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Alberto Davalos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Francois R. Jornayvaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cellular senescence controls fibrosis in wound healing
Joon-Il Jun et al.
AGING-US (2010)
Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
Anna Moles et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
ANNUAL REVIEW OF MEDICINE (2010)
Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
Wan Huang et al.
DIABETES (2010)
Fat Cell-Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
Anil Kumar et al.
DIABETES (2010)
C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis
Amrom E. Obstfeld et al.
DIABETES (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
Rhiannon N. Hardwick et al.
DRUG METABOLISM AND DISPOSITION (2010)
Accumulation of Natural Killer T Cells in Progressive Nonalcoholic Fatty Liver Disease
Wing-Kin Syn et al.
HEPATOLOGY (2010)
Activation of Rac1 Promotes Hedgehog-Mediated Acquisition of the Myofibroblastic Phenotype in Rat and Human Hepatic Stellate Cells
Steve S. Choi et al.
HEPATOLOGY (2010)
The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes
Karlin Raja Karlmark et al.
HEPATOLOGY (2010)
5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α-Induced Hepatocyte Damage in Hyperlipidemia-Prone ApoE-Null Mice
Marcos Martinez-Clemente et al.
HEPATOLOGY (2010)
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Marie-Luise Berres et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity
Raquel Horrillo et al.
JOURNAL OF IMMUNOLOGY (2010)
The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury
Kun Wang et al.
LABORATORY INVESTIGATION (2010)
mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
Shomit Sengupta et al.
NATURE (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease
Silvia Sookoian et al.
PHARMACOGENETICS AND GENOMICS (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1α pathway
Mary D. L. Chau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice Role of Lipoxidation via Receptor-Mediated Mechanisms
Carla Iacobini et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Curcumin Inhibits srebp-2 Expression in Activated Hepatic Stellate Cells in Vitro by Reducing the Activity of Specificity Protein-1
Qiaohua Kang et al.
ENDOCRINOLOGY (2009)
PPARδ ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice
Hyun-Joung Lim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
A Novel Pregnane X Receptor and S14-Mediated Lipogenic Pathway in Human Hepatocyte
Amelie Moreau et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms
Carla Iacobini et al.
JOURNAL OF PATHOLOGY (2009)
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
Bo Kong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
Menno Hoekstra et al.
MOLECULAR PHARMACEUTICS (2009)
Increased expression and activity of the transcription factor FOX01 in nonalcoholic steatohepatitis
Luca Valenti et al.
DIABETES (2008)
Macrophage chemoattractant protein-1 deficiency fails to restrain macrophage infiltration into adipose tissue
Elizabeth A. Kirk et al.
DIABETES (2008)
Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-α control of the acute-phase response
Roxane M. Mansouri et al.
ENDOCRINOLOGY (2008)
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARγ in promoting steatosis
Jie Zhou et al.
GASTROENTEROLOGY (2008)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes
Hong Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
Cheol Soo Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Justin I. Odegaard et al.
NATURE (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation
Ken S. Lau et al.
CELL (2007)
PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1
Shen Qu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
PPARγ agonists prevent TGFβ1 Smad3-signaling in human hepatic stellate cells
Caiyan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
Anna Wieckowska et al.
HEPATOLOGY (2006)
Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro
Emma L. Haughton et al.
GASTROENTEROLOGY (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1α
Ji Miao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
T Nagasawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
NC Henderson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Pregnenolone-16α-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms
CJ Marek et al.
BIOCHEMICAL JOURNAL (2005)
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
E Ip et al.
HEPATOLOGY (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity
G Elad-Sfadia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
T Toyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
M Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
T Claudel et al.
GASTROENTEROLOGY (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation
R Kleemann et al.
BLOOD (2003)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein
JW Park et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
